The Differences of Orthostatic Hypotension in Patients with Parkinson's Disease and Multiple System Atrophy

Overview

Journal Front Neurol

Specialty Neurology

Date 2023 Feb 13

PMID 36779052

Authors

Jingrong Zeng

Yingqi Xing

Shanshan Mei

Baolei Xu

Xiaofan Xue

Haixia Song

Erhe Xu

Affiliations

Soon will be listed here.

Abstract

Background: Multiple system atrophy (MSA) and Parkinson's disease (PD) have similar clinical presentations in their early stages. Orthostatic hypotension (OH) is a common autonomic dysfunction associated with MSA and PD. Heart rate (HR) and systolic blood pressure (SBP) changes are measured in response to the active standing test, which is widely used to screen for cardiovascular autonomic function.

Objectives And Methods: Overall, 255 patients (67 MSA, 188 PD) underwent continuous beat-to-beat non-invasive BP monitoring and active standing test. The total standing time was 10 min, and the BP differences between both groups were compared to determine whether the ΔHR/ΔSBP can differentiate both conditions.

Results: Classical orthostatic hypotension (COH) (52%) and initial OH (19%) were most common in MSA and PD, respectively. MSA had a higher HR (75.0 ± 9.7 vs. 71.0 ± 10.7, = 0.008) than PD in the supine position. SBP (135.70 ± 15.68 mmHg vs. 127.31 ± 15.14 mmHg, = 0.106), diastolic BP (78.45 ± 12.36 mmHg vs. 67.15 ± 13.39 mmHg, = 0.009) and HR (73.94 ± 8.39 bpm vs. 71.08 ± 13.52 bpm, = 0.389) at baseline were higher in MSA-COH than in PD-COH. After adjusting for age and disease duration, the ΔHR/ΔSBP-10 min significantly discriminated MSA-COH from PD-COH ( = 0.031). An ΔHR/ΔSBP-10 min of 0.517 showed a sensitivity of 67% and specificity of 84% (AUC = 0.77, 95% CI: 0.63-0.91).

Conclusion: The SBP, diastolic BP, and HR were higher in the supine position; however, ΔHR and ΔSBP were lower after standing in MSA patients than in PD patients. The ΔHR/ΔSBP-10 min discriminated between MSA-COH and PD-COH with quiet acceptable accuracy.

Citing Articles

Neurogenic Orthostatic Hypotension in Parkinson Disease-A Narrative Review of Diagnosis and Management.

Grosu C, Noea O, Mastaleru A, Ignat E, Leon M J Clin Med. 2025; 14(2).

PMID: 39860637 PMC: 11765550. DOI: 10.3390/jcm14020630.

References

Ahmed A, Ruzieh M, Kanjwal S, Kanjwal K . Syndrome of Supine Hypertension with Orthostatic Hypotension: Pathophysiology and Clinical Approach. Curr Cardiol Rev. 2019; 16(1):48-54. PMC: 7393597. DOI: 10.2174/1573403X15666190617095032. View

Fanciulli A, Campese N, Goebel G, Ndayisaba J, Eschlboeck S, Kaindlstorfer C . Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson disease. Neurology. 2020; 95(21):e2854-e2865. PMC: 7734734. DOI: 10.1212/WNL.0000000000010749. View

Watano C, Shiota Y, Onoda K, Sheikh A, Mishima S, Nitta E . Evaluation of autonomic functions of patients with multiple system atrophy and Parkinson's disease by head-up tilt test. J Neural Transm (Vienna). 2017; 125(2):153-162. DOI: 10.1007/s00702-017-1816-6. View

Kaufmann H, Norcliffe-Kaufmann L, Palma J, Biaggioni I, Low P, Singer W . Natural history of pure autonomic failure: A United States prospective cohort. Ann Neurol. 2017; 81(2):287-297. PMC: 5323269. DOI: 10.1002/ana.24877. View

Pavy-Le Traon A, Piedvache A, Perez-Lloret S, Calandra-Buonaura G, Cochen-De Cock V, Colosimo C . New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study. J Neurol Neurosurg Psychiatry. 2015; 87(5):554-61. DOI: 10.1136/jnnp-2014-309999. View

Fanciulli A, Kerer K, Leys F, Seppi K, Kaufmann H, Norcliffe-Kaufmann L . Validation of the Neurogenic Orthostatic Hypotension Ratio with Active Standing. Ann Neurol. 2020; 88(3):643-645. DOI: 10.1002/ana.25834. View

Postuma R, Berg D, Stern M, Poewe W, Olanow C, Oertel W . MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015; 30(12):1591-601. DOI: 10.1002/mds.26424. View

Nakamura T, Suzuki M, Ueda M, Harada Y, Hirayama M, Katsuno M . Difference in cardiovascular response during orthostatic stress in Parkinson's disease and multiple system atrophy. J Neural Transm (Vienna). 2020; 127(10):1377-1386. DOI: 10.1007/s00702-020-02241-8. View

Goldstein D . Dysautonomia in Parkinson disease. Compr Physiol. 2014; 4(2):805-26. PMC: 4222515. DOI: 10.1002/cphy.c130026. View

10.

Kaufmann H, Jacob G . Early and delayed orthostatic hypotension: Time tells. Neurology. 2015; 85(16):1358-9. DOI: 10.1212/WNL.0000000000002031. View

11.

Velseboer D, de Haan R, Wieling W, Goldstein D, de Bie R . Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2011; 17(10):724-9. PMC: 5199613. DOI: 10.1016/j.parkreldis.2011.04.016. View

12.

Finucane C, van Wijnen V, Fan C, Soraghan C, Byrne L, Westerhof B . A practical guide to active stand testing and analysis using continuous beat-to-beat non-invasive blood pressure monitoring. Clin Auton Res. 2019; 29(4):427-441. DOI: 10.1007/s10286-019-00606-y. View

13.

McDonald C, Newton J, Burn D . Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?. Mov Disord. 2016; 31(7):937-46. DOI: 10.1002/mds.26632. View

14.

Vallelonga F, Sobrero G, Giudici M, Valente M, Milazzo V, Di Stefano C . Screening indexes for cardiovascular autonomic failure in Parkinson's disease. J Neurol Sci. 2021; 428:117571. DOI: 10.1016/j.jns.2021.117571. View

15.

Wieling W, Krediet C, van Dijk N, Linzer M, Tschakovsky M . Initial orthostatic hypotension: review of a forgotten condition. Clin Sci (Lond). 2007; 112(3):157-65. DOI: 10.1042/CS20060091. View

16.

Tomlinson C, Stowe R, Patel S, Rick C, Gray R, Clarke C . Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord. 2010; 25(15):2649-53. DOI: 10.1002/mds.23429. View

17.

Coon E, Cutsforth-Gregory J, Benarroch E . Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord. 2018; 33(3):349-358. DOI: 10.1002/mds.27186. View

18.

Gilman S, Wenning G, Low P, Brooks D, Mathias C, Trojanowski J . Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008; 71(9):670-6. PMC: 2676993. DOI: 10.1212/01.wnl.0000324625.00404.15. View

19.

Peto V, Jenkinson C, Fitzpatrick R, Greenhall R . The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1995; 4(3):241-8. DOI: 10.1007/BF02260863. View

20.

Storch A, Schneider C, Klingelhofer L, Odin P, Fuchs G, Jost W . Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS). J Neural Transm (Vienna). 2015; 122(12):1673-84. DOI: 10.1007/s00702-015-1437-x. View